DOJOLVI
DOJOLVI
Approved
DIN Number
02512556
Drug Class
Human
Market Date
Apr 1, 2021
Company
HC
ULTRAGENYX PHARMACEUTICAL INC
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02512556
AIG Number0162765001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
A16AX17 TRIHEPTANOIN
Product Specifications
Dosage FormLiquid
Route of AdministrationOral
AHFS Classification40:20.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
TRIHEPTANOINActive
Strength: 100 % / W/W
Monograph: TRIHEPTANOIN